(Q37349633)

19 August 2017

1 reference

title

Current treatment of metastatic endometrial cancer (English)

1 reference

19 August 2017

Sarah M Temkin

1

1 reference

PubMed ID

19078928

19 August 2017

Gini Fleming

series ordinal

2

1 reference

19 August 2017

1 January 2009

1 reference

19 August 2017

1 reference

19 August 2017

16

1 reference

19 August 2017

1

1 reference

19 August 2017

38-45

1 reference

19 August 2017

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Pelvic exenteration for recurrent endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Surgical resection of recurrent endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Hormone therapy in advanced and recurrent endometrial cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Arzoxifene as therapy for endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers--a study of the National Cancer Institute of Canada Clinical Trials Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Goserelin acetate as treatment for recurrent endometrial carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Epirubicin in advanced endometrial adenocarcinoma: a phase II study of the grupo ginecologico Español para el tratamiento oncologico (GGETO)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Systemic therapy in metastatic or recurrent endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Treatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Phase II trial of 3-h infusion of paclitaxel in patients with adenocarcinoma of endometrium: Japanese Multicenter Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Phase II trial of the pegylated liposomal doxorubicin in previously treated metastatic endometrial cancer: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Systemic chemotherapy for uterine carcinoma: metastatic and adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Paclitaxel and carboplatin in the treatment of advanced or recurrent endometrial cancer: a large retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: a Gynecologic Oncology Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600106

10.1177/107327480901600106

21 January 2018

Identifiers

DOI

0 references

PubMed ID

19078928

1 reference

PubMed ID

19078928